Filter
448
Text search:
immunocompromised
Featured
Recommendations
56
New Publications
72
Language
Document type
No document type
166
Guidelines
151
Studies & Reports
56
Manuals
25
Fact sheets
23
Strategic & Response Plan
12
Training Material
7
Situation Updates
3
Infographics
3
Brochures
1
Resource Platforms
1
Countries / Regions
India
26
Western and Central Europe
16
Latin America and the Carribbean
12
South Africa
11
Global
11
Kenya
7
Africa
7
Philippines
5
Syria
5
Middle East and North Africa
5
Nigeria
4
Mozambique
4
Ukraine
4
West and Central Africa
4
Eastern Europe and Central Asia
4
Germany
3
Zambia
3
Tanzania
3
Rwanda
3
Malawi
3
Namibia
3
Brazil
3
East and Southern Africa
3
South–East Asia Region
3
Venezuela
3
Eastern Europe
3
Russia
3
Congo, Democratic Republic of
2
Mali
2
USA
2
Ethiopia
2
Niger
2
Nepal
2
Indonesia
2
Argentina
2
Myanmar / Burma
2
Chile
2
Yemen
2
Burkina Faso
1
Senegal
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Saudi Arabia
1
Cameroon
1
Ghana
1
Uganda
1
Zimbabwe
1
Haiti
1
Somalia
1
Pakistan
1
South Sudan
1
Iraq
1
Jordan
1
Afghanistan
1
Lebanon
1
Egypt
1
Chad
1
Mauritania
1
Bangladesh
1
Singapore
1
Sudan
1
Benin
1
Dominican Republic
1
Peru
1
Eswatini/ Swaziland
1
North Macedonia
1
Cuba
1
Colombia
1
Honduras
1
Ecuador
1
El Salvador
1
Bolivia
1
Libya
1
Guatemala
1
Madagascar
1
Lesotho
1
Mexico
1
Nicaragua
1
Sri Lanka
1
Western Pacific Region
1
Asia
1
Albania
1
Congo-Brazzaville
1
Qatar
1
Kazakhstan
1
Georgia
1
North America
1
France
1
Tunisia
1
Spain
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
120
Clinical Guidelines
79
Key Resources
13
Public Health
12
Women & Child Health
12
Pharmacy & Technologies
9
Capacity Building
1
Toolboxes
COVID-19
118
TB
61
HIV
31
Rapid Response
24
AMR
22
NTDs
21
Refugee
10
Planetary Health
10
Ebola & Marburg
7
Cholera
6
Polio
5
Conflict
5
Mental Health
5
Caregiver
5
Pharmacy
5
Malaria
5
2.0 Rapid Response
5
Zika
4
Disability
3
Natural Hazards
3
Global Health Education
2
Health Financing Toolbox
1
Standard Treatment Guideline
This guide focuses on three main areas: how to support a person whose condition warrants home care because of non-severe symptoms and home care is recommended by local jurisdictions; how to prevent the spread of COVID-19 in the home; and how to provide emotional support to family members. While this
...
orientations provisoires, première publication : 8 janvier 2021, mise à jour : 15 juin 2021, mise à jour : 19 novembre 2021, mise à jour : 21 janvier 2022
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th
...
Nature | Vol 600 | 2 December 2021 |
It is estimated that more than 311 000 women die of cervical
cancer each year. Of these deaths, 91% occur in low- and
middle-income countries. Demographic changes and a lack of
action mean that the number of deaths per year is projected
to reach 460 000 by 2040.
Standard Treatment Guideline
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern. In the fight against TB, urgent investment is critical, especially in the context of the ongoing pandemic.
Updated guidance. The guidance provides useful information to staff working in prisons, as well as to health and prison authorities, explaining how to prevent and address a potential outbreak of COVID-19. In addition, it aims to protect the health and well-being of all those who live and work in, an
...
This protocol provides an approach for public health authorities and investigators at all levels to plan for and conduct investigations of nonseasonal influenza and other emerging respiratory diseases and provides tips and reminders for linking the information from the investigation with risk assess
...
Smallpox eradication was certified in 1980. Mpox has been endemic in Central and West African countries since it was first detected in 1958 . It is a zoonosis; cases are often found close to tropical rainforests where various animals carry the orthopoxvirus that causes the disease. In endemic countr
...
Declarations of interests were collected from all external contributors and assessed for any conflicts of interest. Summaries of the reported interests can be found on the SAGE meeting website and SAGE Covid-19 Working Group webpage. This guidance should be considered along with the broader COVID-
...
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations.
It covers the following items:
Global Reports
Immunization Agenda 2030 and Regional reports
Monkeypox
RSV
COVID-19 vacci
...
Regional implementation framework for elimination of cervical cancer as a public health problem: 2021–2030
recommended
Cervical cancer continues to be a significant public health problem and a major cause of premature mortality among women, disproportionately affecting the socioeconomically disadvantaged population in low- and middle-income countries (LMICs). In the absence of implementing the known evidence-based,
...
Over nine years of protracted and violent conflict in Syria has decimated its health system,killed an estimated 586,000 people and forcibly displaced more than half the 22 million pre-war population from their homes. As of June 2020, a total of 6.2 million Syrians (of whom 40% are children) are inte
...
In Control. A Practical Handbook for Professionals Working in Health Emergencies Internationally
recommended
In Control imparts knowledge, provokes reflection and triggers curiosity. The first half of the book provides an overview of the organisations, principles, frameworks and themes that every professional deploying to health emergencies should be aware of. The second half of the book provides practical
...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
